Abstract

Mitochondria adapt to changing energetic demands of the cell. We recently reported that mitochondrial membrane lipid composition represents a regulatory mechanism by which effciency of oxidative phosphorylation becomes altered. Metabolic-associated fatty liver disease (MAFLD) is a progressive disorder characterized by oxidative stress and accumulation of fat in hepatocytes that can lead to metabolic dysfunction-associated steatohepatitis (MASH). We hypothesized that MAFLD alters mitochondrial membrane lipids to induce mitochondrial electron transfer ineffciency and promotes oxidative stress. Lipid mass spectrometric analyses in four models of MAFLD (high-fat diet, ob/ob, carbon tetrachloride administration (CCI4), and Gubra-Amylin-NASH® diet), revealed that low mitochondrial cardiolipin (CL) is a common signature associated with all MAFLD models. In hepa1-6 cells, lentivirus-mediated knockdown of cardiolipin synthase (CLS, generates CL in mitochondria) was suffcient to reduce respiration and increase electron leak. Liver mitochondria from mice with a hepatocyte-specific knockout of CLS exhibited defects in mitochondrial bioenergetics including increased electron leak, concomitant to pathogenesis of MASH. Together, these findings provide evidence that a reduction in hepatic cardiolipin may drive the progression of MAFLD to induce MASH pathology. R01GM144613-03R01AG074535-02S2R01DK107397 07. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call